GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Phase 4

Completed

Conditions: Herpes Genitalis

Interventions: Drug: Valaciclovir
Drug: Placebo

First Posted Date: 2005-09-12

Last Posted Date: 2019-02-15

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 384

Registration Number: NCT00158860

Locations: 🇨🇱
GSK Investigational Site, Santiago, Región Metro De Santiago, Chile

Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine

Phase 4

Completed

Conditions: Haemophilus Influenzae Type b Disease

First Posted Date: 2005-09-12

Last Posted Date: 2017-05-30

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 454

Registration Number: NCT00158795

Locations: 🇨🇳
GSK Investigational Site, Nanning, Guangxi, China

Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Phase 4

Completed

Conditions: Sedation

First Posted Date: 2005-09-12

Last Posted Date: 2008-10-16

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 224

Registration Number: NCT00158873

Locations: 🇳🇱
GSK Investigational Site, Zwolle, Netherlands

Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications

Phase 3

Completed

Conditions: Asthma

First Posted Date: 2005-09-12

Last Posted Date: 2008-10-13

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 200

Registration Number: NCT00158834

Locations: 🇳🇱
GSK Investigational Site, Zwolle, Netherlands

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

Phase 3

Completed

Conditions: Hepatitis B

Interventions: Biological: Rotarix™
Biological: Tritanrix™-HepB
Biological: Triple Antigen™
Drug: Placebo
Biological: Engerix™-B
Biological: Zilbrix™

First Posted Date: 2005-09-12

Last Posted Date: 2018-06-06

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 308

Registration Number: NCT00158756

Locations: 🇷🇺
GSK Investigational Site, Tomsk, Russian Federation

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

Phase 1

Completed

Conditions: Neoplasms, Breast

Interventions: Drug: lapatinib
Drug: docetaxel

First Posted Date: 2005-09-08

Last Posted Date: 2017-12-06

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 52

Registration Number: NCT00148902

Locations: 🇺🇸
GSK Investigational Site, Nashville, Tennessee, United States

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Phase 1

Completed

Conditions: Neoplasms, Prostate

First Posted Date: 2005-09-08

Last Posted Date: 2017-06-02

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 25

Registration Number: NCT00148928

Locations: 🇫🇷
GSK Investigational Site, Villejuif Cedex, France

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Phase 3

Completed

Conditions: Diphtheria
Tetanus
Acellular Pertussis

Interventions: Biological: SB213503 lot 3
Biological: Infanrix
Biological: SB213503 lot 1
Biological: SB213503 lot 2
Biological: IPOL
Biological: M-M-R II